Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.44 USD | +0.42% | -1.61% | -37.11% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 77.52M |
---|---|---|---|---|---|
Net income 2024 * | -14M | Net income 2025 * | -15M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.52
x | P/E ratio 2025 * |
-5.4
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.09% |
Latest transcript on Anixa Biosciences, Inc.
1 day | +0.41% | ||
1 week | -1.61% | ||
Current month | +0.42% | ||
1 month | -17.00% | ||
3 months | -34.41% | ||
6 months | -33.87% | ||
Current year | -37.11% |
Managers | Title | Age | Since |
---|---|---|---|
Amit Kumar
CEO | Chief Executive Officer | 59 | 12-10-31 |
Michael Catelani
DFI | Director of Finance/CFO | 57 | 16-10-31 |
Pamela Garzone
PRN | Corporate Officer/Principal | 70 | 21-09-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Titterton
BRD | Director/Board Member | 79 | 99-06-30 |
Amit Kumar
CEO | Chief Executive Officer | 59 | 12-10-31 |
Emily Gottschalk
BRD | Director/Board Member | 63 | 19-10-22 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 2.44 | +0.42% | 35 436 |
24-05-31 | 2.43 | -4.33% | 54,322 |
24-05-30 | 2.54 | +2.42% | 46,333 |
24-05-29 | 2.48 | 0.00% | 39,090 |
24-05-28 | 2.48 | +2.69% | 57,951 |
Delayed Quote Nasdaq, June 03, 2024 at 12:50 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.11% | 77.52M | |
+45.45% | 54.63B | |
-6.96% | 39.92B | |
+37.07% | 38.82B | |
+13.17% | 26.86B | |
-11.17% | 26.22B | |
-21.90% | 18.78B | |
+24.95% | 12.21B | |
+0.32% | 12.16B | |
+24.93% | 11.94B |
- Stock Market
- Equities
- ANIX Stock